However, it was previously reported that during anti-cancer drugs mediated-apoptosis, activation of ERK could trigger cell death by reducing mitochondrial membrane potential and mitochondrial respiration, which could promote cytochrome C release [33,34]. Here, CYCS is linked to cancer.